Postexercise nutrition is a critical component of an athlete’s recovery from training and competition. However, little is known about athletes’ postexercise dietary practices or knowledge of dietary recommendations, particularly among masters athletes. The purpose of this study was to compare and contrast the knowledge of postexercise nutritional recommendations, and typical postexercise intakes of carbohydrate and protein, between masters and younger triathletes. 182 triathletes (Male = 101, Female = 81) completed an online survey distributed by Triathlon Australia. Knowledge of postexercise nutrition recommendations for protein and carbohydrate intake were assessed as a group, and contrasted between subgroups of masters (≥50 years) and younger triathletes (≤30 years). Using dietary recall, postexercise intakes of carbohydrate and protein were examined and contrasted between masters and younger triathletes. As a group, 43.1% and 43.9% of all triathletes answered, “I don’t know” when asked to identify the recommended postexercise carbohydrate and protein intakes, respectively. Dietary analysis revealed masters triathletes consumed significantly less carbohydrate (0.7 ± 0.4 g.kg-1) postexercise than recommended (1.0 g.kg-1; p = .001), and in comparison with younger triathletes (1.1 ± 0.6 g.kg-1; p = .01). Postexercise protein intakes were similar between masters (19.6 ± 13.5 g) and younger (26.4 ± 15.8 g) triathletes. However, relative to body mass, masters triathletes consumed significantly less protein (0.3 ± 0.2 g.kg-1) than younger triathletes (0.4 ± 0.2 g.kg-1; p = .03), and consumed significantly less energy postexercise (22.7 ± 11.7 kJ.kg-1) than younger triathletes (37.8 ± 19.2 kJ.kg-1; p = .01). The present data suggests triathletes have poor knowledge of recommendations for postexercise carbohydrate and protein intakes. Furthermore, low postexercise intakes of carbohydrate and protein by masters athletes may impair acute recovery.
Thomas M. Doering, Peter R. Reaburn, Gregory Cox and David G. Jenkins
Thomas M. Doering, Peter R. Reaburn, Stuart M. Phillips and David G. Jenkins
Participation rates of masters athletes in endurance events such as long-distance triathlon and running continue to increase. Given the physical and metabolic demands of endurance training, recovery practices influence the quality of successive training sessions and, consequently, adaptations to training. Research has suggested that, after muscle-damaging endurance exercise, masters athletes experience slower recovery rates in comparison with younger, similarly trained athletes. Given that these discrepancies in recovery rates are not observed after non–muscle-damaging exercise, it is suggested that masters athletes have impairments of the protein remodeling mechanisms within skeletal muscle. The importance of postexercise protein feeding for endurance athletes is increasingly being acknowledged, and its role in creating a positive net muscle protein balance postexercise is well known. The potential benefits of postexercise protein feeding include elevating muscle protein synthesis and satellite cell activity for muscle repair and remodeling, as well as facilitating muscle glycogen resynthesis. Despite extensive investigation into age-related anabolic resistance in sedentary aging populations, little is known about how anabolic resistance affects postexercise muscle protein synthesis and thus muscle remodeling in aging athletes. Despite evidence suggesting that physical training can attenuate but not eliminate age-related anabolic resistance, masters athletes are currently recommended to consume the same postexercise dietary protein dose (approximately 20 g or 0.25 g/kg/meal) as younger athletes. Given the slower recovery rates of masters athletes after muscle-damaging exercise, which may be due to impaired muscle remodeling mechanisms, masters athletes may benefit from higher doses of postexercise dietary protein, with particular attention directed to the leucine content of the postexercise bolus.
Scott C. Forbes, Linda McCargar, Paul Jelen and Gordon J. Bell
The purpose was to investigate the effects of a controlled typical 1-day diet supplemented with two different doses of whey protein isolate on blood amino acid profiles and hormonal concentrations following the final meal. Nine males (age: 29.6 ± 6.3 yrs) completed four conditions in random order: a control (C) condition of a typical mixed diet containing ~10% protein (0.8 g·kg–1), 65% carbohydrate, and 25% fat; a placebo (P) condition calorically matched with carbohydrate to the whey protein conditions; a low-dose condition of 0.8 grams of whey protein isolate per kilogram body mass per day (g·kg–1·d–1; W1) in addition to the typical mixed diet; or a high-dose condition of 1.6 g·kg–1·d–1 (W2) of supplemental whey protein in addition to the typical mixed diet. Following the final meal, significant (p < .05) increases in total amino acids, essential amino acids (EAA), branch-chained amino acids (BCAA), and leucine were observed in plasma with whey protein supplementation while no changes were observed in the control and placebo conditions. There was no significant group difference for glucose, insulin, testosterone, cortisol, or growth hormone. In conclusion, supplementing a typical daily food intake consisting of 0.8 g of protein·kg–1·d–1 with a whey protein isolate (an additional 0.8 or 1.6 g·kg–1·d–1) significantly elevated total amino acids, EAA, BCAA, and leucine but had no effect on glucose, insulin, testosterone, cortisol, or growth hormone following the final meal. Future acute and chronic supplementation research examining the physiological and health outcomes associated with elevated amino acid profiles is warranted.
Stephen F. Burns, Masashi Miyashita, Chihoko Ueda and David J. Stensel
The present study examined how multiple bouts of resistance exercise, performed over 1 d, influence 2 risk factors—postprandial triacylglycerol (TAG) and serum C-reactive-protein (CRP) concentrations—associated with coronary heart disease. Twenty-four men age 23.5 (SD 3.4) y completed two 2-d trials, exercise and control, at least 1 wk apart in a counterbalanced randomized design. On day 1 of the exercise trials participants completed 20 sets of 15 repetitions of 5 different resistance exercises divided into five 45-min bouts of exercise—100 sets and 1500 repetitions in total for all exercises. Exercises were performed at 30–40% of 1-repetition maximum. Blood samples were taken before and after exercise. On day 1 of the control trial participants were inactive, with blood samples taken at time points corresponding to the exercise trial. On day 2 of both trials participants consumed a test meal (0.89 g fat, 1.23 g carbohydrate, 0.4 g protein, 60 kJ per kg body mass). Blood samples were obtained fasted and for 6 h post prandially. Total area under the postprandial TAG concentration versus time curve was 12% lower in the exercise than in the control trial (8.76 [3.54] vs. 9.94 [4.31] mmol·L-1·6 h, respectively; P = 0.037). Serum CRP concentrations did not change over the 2 d in the control trial but increased in the exercise trial: trial × time interaction (P = 0.028). Multiple bouts of resistance exercise reduce postprandial TAG concentrations but increase serum CRP concentrations. The extent to which these findings are clinically relevant requires further study.
Rudy J. Valentine, Michael J. Saunders, M. Kent Todd and Thomas G. St. Laurent
Carbohydrate–protein (CHO+Pro) beverages reportedly improve endurance and indices of muscle disruption, but it is unclear whether these effects are related to total energy intake or specific effects of protein.
The authors examined effects of CHO+Pro on time to exhaustion and markers of muscle disruption compared with placebo (PLA) and carbohydrate beverages matched for carbohydrate (CHO) and total calories (CHO+CHO).
Eleven male cyclists completed 4 rides to exhaustion at 75% VO2peak. Participants consumed 250 ml of PLA, CHO (7.75%), CHO+CHO (9.69%), or CHO+Pro (7.75%/1.94%) every 15 min until fatigue, in a double-blind design.
Time to exhaustion was significantly longer (p < .05) in CHO+Pro (126.2 ± 25.4 min) and CHO+CHO (121.3 ± 36.8) than PLA (107.1 ± 30.3). CHO (117.5 ± 24.2) and PLA were not significantly different. Similarly, CHO+Pro was not significantly different from CHO and CHO+CHO. Postexercise plasma creatine kinase was lower after CHO+Pro (197.2 ± 149.2 IU/L) than PLA (407.4 ± 391.3), CHO (373.2 ± 416.6), and CHO+CHO (412.3 ± 410.2). Postexercise serum myoglobin was lower in CHO+Pro (47.0 ± 27.4 ng/mL) than all other treatments (168.8 ± 217.3, 82.6 ± 71.3, and 72.0 ± 75.8). Postexercise leg extensions at 70% 1RM were significantly greater 24 hr after CHO+Pro (11.3 ± 4.1) than PLA (8.8 ± 3.7), CHO (9.7 ± 4.3), and CHO+CHO (9.5 ± 3.6).
These findings suggest that at least some of the reported improvements in endurance with CHO+Pro beverages might be related to caloric differences between treatments. Postexercise improvements in markers of muscle disruption with CHO+Pro ingestion appear to be independent of carbohydrate and caloric content and were elicited with beverages consumed only during exercise.
Stephen M. Cornish, Darren G. Candow, Nathan T. Jantz, Philip D. Chilibeck, Jonathan P. Little, Scott Forbes, Saman Abeysekara and Gordon A. Zello
The authors examined the combined effects of conjugated linoleic acid (CLA), creatine (C), and whey protein (P) supplementation during strength training.
Sixty-nine participants (52 men, 17 women; M ± SD age 22.5 ± 2.5 yr) were randomly assigned (double-blind) to 1 of 3 groups: CCP (6 g/d CLA + 9 g/d C + 36 g/d P; n = 22), CP (C + P + placebo oil; n = 25), or P (P + placebo oil; n = 22) during 5 wk of strength training (4–5 sets, 6–12 repetitions, 6 d/wk). Measurements were taken for body composition (air-displacement plethysmography), muscle thickness (ultrasound) of the flexors and extensors of the elbow and knee, 1-repetitionmaximum (1-RM) strength (leg press and bench press), urinary markers of bone resorption (N-telopeptides, NTx), myofibrillar protein catabolism (3-methylhistidine; 3-MH), oxidative stress (8-isoprostanes), and kidney function (microalbumin) before and after training.
Contrast analyses indicated that the CCP group had a greater increase in bench-press (16.2% ± 11.3% vs. 9.7% ± 17.0%; p < .05) and legpress (13.1% ± 9.9% vs. 7.7% ± 14.2%; p < .05) strength and lean-tissue mass (2.4% ± 2.8% vs. 1.3% ± 4.1%; p < .05) than the other groups combined. All groups increased muscle thickness over time (p < .05). The relative change in 3-MH (CCP –4.7% ± 70.2%, CP –0.4% ± 81.4%, P 20.3% ± 75.2%) was less in the groups receiving creatine (p < .05), with the difference for NTx also close to significance (p = .055; CCP–3.4% ± 66.6%, CP–3.9% ± 64.9%, P 26.0% ± 63.8%). There were no changes in oxidative stress or kidney function.
Combining C, CLA, and P was beneficial for increasing strength and lean-tissue mass during heavy resistance training.
Michael J. Saunders, Rebecca W. Moore, Arie K. Kies, Nicholas D. Luden and Casey A. Pratt
This study examined whether a carbohydrate + casein hydrolysate (CHO+ProH) beverage improved time-trial performance vs. a CHO beverage delivering ~60 g CHO/hr. Markers of muscle disruption and recovery were also assessed. Thirteen male cyclists (VO2peak = 60.8 ± 1.6 ml · kg−1 · min−1) completed 2 computer-simulated 60-km time trials consisting of 3 laps of a 20-km course concluding with a 5-km climb (~5% grade). Participants consumed 200 ml of CHO (6%) or CHO+ProH beverage (6% + 1.8% protein hydrolysate) every 5 km and 500 ml of beverage immediately postexercise. Beverage treatments were administered using a randomly counterbalanced, double-blind design. Plasma creatine phosphokinase (CK) and muscle-soreness ratings were assessed immediately before and 24 hr after cycling. Mean 60-km times were 134.4 ± 4.6 and 135.0 ± 4.0 min for CHO+ProH and CHO beverages, respectively. All time differences between treatments occurred during the final lap, with protein hydrolysate ingestion explaining a significant (p < .05) proportion of betweentrials differences over the final 20 km (44.3 ± 1.6, 45.0 ± 1.6 min) and final 5 km (16.5 ± 0.6, 16.9 ± 0.6 min). Plasma CK levels and muscle-soreness ratings increased significantly after the CHO trial (161 ± 53, 399 ± 175 U/L; 15.8 ± 5.1, 37.6 ± 5.7 mm) but not the CHO+ProH trial (115 ± 21, 262 ± 88 U/L; 20.9 ± 5.3, 32.2 ± 7.1 mm). Late-exercise time-trial performance was enhanced with CHO+ProH beverage ingestion compared with a beverage containing CHO provided at maximal exogenous oxidation rates during exercise. CHO+ProH ingestion also prevented increases in plasma CK and muscle soreness after exercise.
Jeffrey B. Driban, Easwaran Balasubramanian, Mamta Amin, Michael R. Sitler, Marvin C. Ziskin and Mary F. Barbe
Joint trauma is a risk factor for osteoarthritis (OA), which is becoming an increasingly important orthopedic concern for athletes and nonathletes alike. For advances in OA prevention, diagnosis, and treatment to occur, a greater understanding of the biochemical environment of the affected joint is needed.
To demonstrate the potential of a biochemical technique to enhance our understanding of and diagnostic capabilities for osteoarthritis.
Outpatient orthopedic practice.
8 subjects: 4 OA-knee participants (65 ± 6 y of age) and 4 normal-knee participants (54 ± 10 y) with no history of knee OA based on bilateral standing radiographs.
The independent variable was group (OA knee, normal knee).
Main Outcome Measures:
16 knee synovial-protein concentrations categorized as follows: 4 as pro-inflammatory, or catabolic, cytokines; 5 as anti-inflammatory, or protective, cytokines; 3 as catabolic enzymes; 2 as tissue inhibitors of metalloproteinases [TIMPs]; and 2 as adipokines.
Two anti-inflammatory cytokines (interleukin [IL]-13 and osteoprotegerin) and a pro-inflammatory cytokine (IL-1β) were significantly lower in the OA knees. Two catabolic enzymes (matrix metalloproteinase [MMP]-2 and MMP-3) were significantly elevated in OA knees. TIMP-2, an inhibitor of MMPs, was significantly elevated in OA knees.
Six of the 16 synovial-fluid proteins were significantly different between OA knees and normal knees in this study. Future research using a similar multiplex ELISA approach or other proteomic techniques may enable researchers and clinicians to develop more accurate biochemical profiles of synovial fluid to help diagnose OA, identify subsets of OA or individual characteristics, guide clinical decisions, and identify patients at risk for OA after knee injury.
Zekine Lappalainen, Jani Lappalainen, David E. Laaksonen, Niku K.J Oksala, Savita Khanna, Chandan K. Sen and Mustafa Atalay
Thioredoxin (TRX) is a protein disulfide reductase that plays an important role in many thiol-dependent cellular reductive processes, antioxidant protection, and signal transduction. Moreover, TRX reduces and maintains the function of many proteins during oxidative stress, which is increased in diabetes. The authors recently reported that diabetes impairs brain redox status and TRX response to exercise training. As a continuation of their studies, they hypothesized that alpha-lipoic acid, a natural thiol antioxidant, has a favorable effect on the brain TRX and glutathione (GSH) system in diabetes. Streptozotocin-induced diabetes was used as a chronic model and exhaustive exercise as an acute model for disrupted redox balance. Half the diabetic and nondiabetic animals were subjected to a bout of exhaustive exercise after 8 wk with or without lipoic acid and analyzed for key thiol antioxidants. Lipoic acid neither altered diabetes-induced oxidative stress as assessed by the increased ratio of oxidized to total GSH nor had any impact on the antioxidant protein response to exercise. However, lipoic acid increased mRNA of TRX-interacting protein, an inhibitor of TRX-1, and glutaredoxin-1 in diabetes. Exercise increased TRX-1 mRNA in both diabetic and nondiabetic animals but had no effect on TRX-1 protein. Cytosolic superoxide dismutase mRNA was only increased in diabetes, whereas exercise increased the protein levels in nondiabetic animals. The findings suggest that exhaustive exercise induces mRNA of TRX-1 in the brain and that lipoic acid cannot prevent diabetes-induced disturbances in GSH homeostasis. Because lipoic acid increased TRX-interacting protein transcription in diabetes, high doses may impair TRX-1 homeostasis.
Eric R. Helms, Caryn Zinn, David S. Rowlands and Scott R. Brown
Caloric restriction occurs when athletes attempt to reduce body fat or make weight. There is evidence that protein needs increase when athletes restrict calories or have low body fat.
The aims of this review were to evaluate the effects of dietary protein on body composition in energy-restricted resistance-trained athletes and to provide protein recommendations for these athletes.
Database searches were performed from earliest record to July 2013 using the terms protein, and intake, or diet, and weight, or train, or restrict, or energy, or strength, and athlete. Studies (N = 6) needed to use adult (≥ 18 yrs), energy-restricted, resistance-trained (> 6 months) humans of lower body fat (males ≤ 23% and females ≤ 35%) performing resistance training. Protein intake, fat free mass (FFM) and body fat had to be reported.
Body fat percentage decreased (0.5–6.6%) in all study groups (N = 13) and FFM decreased (0.3–2.7kg) in nine of 13. Six groups gained, did not lose, or lost nonsignificant amounts of FFM. Five out of these six groups were among the highest in body fat, lowest in caloric restriction, or underwent novel resistance training stimuli. However, the one group that was not high in body fat that underwent substantial caloric restriction, without novel training stimuli, consumed the highest protein intake out of all the groups in this review (2.5–2.6g/kg).
Protein needs for energy-restricted resistance-trained athletes are likely 2.3–3.1g/kg of FFM scaled upwards with severity of caloric restriction and leanness.